Market revenue in 2022 | USD 652.9 million |
Market revenue in 2030 | USD 1,664.9 million |
Growth rate | 12.4% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.42% in 2022. Horizon Databook has segmented the Japan molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Being the most technologically advanced country, the biotechnology industry in Japan is among the most developed biotechnology sectors in the world. This can be attributed to supportive government strategies along with the increasing investments from the global players.
The Japanese government has boosted the biotechnology development in the country by funding various research institutions. For instance, Okinawa Health Biotechnology Research and Development Center is funded by government, which offers free research facilities.
The center is aiming to enhance government-industry-academia collaborations to improve product manufacturing. Such increasing initiatives by government are anticipated to propel the market growth for molecular biology enzymes, kits, and reagents in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into Japan molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account